Abstract:Magnetic resonance imaging(MRI) has been extensively used in clinical diagnosis and currently over 30% MRI runs are performed in the presence of contrast agents. However, commercially available contrast agents originated from small molecules typically exhibit relatively low relaxivities and insufficient circulation time. Therefore, there is a long pursuit to develop new contrast agents with high relaxivities to discriminate pathological tissues from normal ones. Compared with small molecule MRI contrast agents, the incorporation of small molecule contrast agents into macromolecular scaffolds allows for constructing macromolecular MRI contrast agents, remarkably elevating the relaxivities due in part to increased rotational correlation time(τR). Moreover, if the macromolecular scaffolds are responsive to external stimuli, the MRI signals could be selectively switched on at the desired sites(e.g., pathological tissues), further intensifying the imaging contrast. In this feature article, we outline the recent achievements in the fabrication of stimuli-responsive macromolecular MRI contrast agents. Specifically, macromolecular contrast agents being responsive to acidic p H, redox potentials, and other stimuli including photoirradiation, pathogens, and salt concentration are discussed. These smart contrast agents could affect either longitudinal(T1) or transverse(T2) relaxation times of water protons or other nuclei(e.g.,19 F), exhibiting enhanced signals in pathological tissues yet suppressed signals in normal ones and displaying promising potentials in in vitro and in vivo MRI applications.

Development of Magnetic Resonance Imaging Contrast Agents with PAMAM Dendrimer Cores

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application

Research Progress of Magnetic Resonance Imaging Contrast Agents

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Targeted Biodegradable Dendritic MRI Contrast Agent for Enhanced Tumor Imaging

A Dendritic Supramolecular Complex As Uniform Hybrid Micelle with Dual Structure for Bimodal in Vivo Imaging

A Dendritic Supramolecular Complex as Uniform Hybrid Micelle with Dual Structure for Bimodal In Vivo Imaging.

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Biocompatible Supramolecular Dendrimers Bearing a Gadolinium-Substituted Polyanionic Core for MRI Contrast Agents

Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent

Macromolecular MRI Contrast Agents: Structures, Properties and Applications

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Recent Advances on Stimuli-Responsive Macromolecular Magnetic Resonance Imaging (MRI) Contrast Agents